Research and Markets: Atopic Dermatitis Therapeutics - An Essential Source Of Information And Analysis On The Global Market Out Now

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/06cc0a/atopic_dermatitis) has announced the addition of GlobalData's new report "Atopic Dermatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018" to their offering.

“Atopic Dermatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018”

Atopic Dermatitis Therapeutics Market is Forecast to Show Significant Growth until 2018

Steady Increase in Disease Population to Strengthen Present Market

GlobalData, the industry analysis specialist, has released its new report, Atopic Dermatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018. The report identifies the key trends shaping and driving the global Atopic Dermatitis Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Atopic Dermatitis Therapeutics sector.

Scope:

• Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Atopic Dermatitis Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2017.
• Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
• Analysis of the current and future competition in the seven key countries.
• Insightful review of the key industry drivers, restraints and challenges.
• Strategic competitor assessment, market characterization, unmet needs and the implications for the market.
• Analysis of key recent licensing and partnership agreements.

Reasons to Buy:

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global market in future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Identify the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Companies Mentioned:

• Almirall
• Anacor Pharmaceuticals
• BioCis Pharmaceuticals
• MIKA Pharma GmbH

For more information visit http://www.researchandmarkets.com/research/06cc0a/atopic_dermatitis